134
Views
5
CrossRef citations to date
0
Altmetric
Original Research

Custom fractional factorial designs to develop atorvastatin self-nanoemulsifying and nanosuspension delivery systems – enhancement of oral bioavailability

, , &
Pages 3141-3152 | Published online: 19 Jun 2015

References

  • AhmedOAAHosnyKMAl-SawahliMMFahmyUAOptimization of caseinate coated simvastatin-zein nanoparticles: improved bioavailability and modified release characteristicsDrug Des Devel Ther20159655662
  • MalhotraHSGoaKLAtorvastatin: an updated review of its pharmacological properties and use in dyslipidaemiaDrugs2001611835188111693468
  • LeaAPMcTavishDAtorvastatin. A review of its pharmacology and therapeutic potential in the management of hyperlipidaemiasDrugs1997538288479129869
  • FatourosDGDeenGRArlethLStructural development of self nano emulsifying drug delivery systems (SNEDDS) during in vitro lipid digestion monitored by small-angle X-ray scatteringPharm Res2007241844185317458683
  • NazzalSSmalyukhILavrentovichOKhanMPreparation and in vitro characterization of a eutectic based semisolid selfnanoemulsified drug delivery system (SNEDDS) of ubiquinone: mechanism and progress of emulsion formationInt J Pharm200223524726511879759
  • PreshitaPAbhijitADVandanaBPOvercoming poor oral bioavailability using nanoparticle formulations opportunities and limitationsDrug Discov Today Technol20029e87e95
  • DateADesaiNDixitRNagersankerMSelf-nanoemulsifying drug delivery systems: formulation insights, applications and advancesNanomedicine (Lond)201051595161621143036
  • ElkasabgyNAOcular supersaturated self-nanoemulsifying drug delivery systems (S-SNEDDS) to enhance econazole nitrate bioavailabilityInt J Pharm2014460334424184217
  • CuineJFMcEvoyCLCharmanWNEvaluation of the impact of surfactant digestion on the bioavailability of danazol after oral administration of lipidic self-emulsifying formulations to dogsJ Pharm Sci200897995101218064698
  • BalakumarKRaghavanCVSelvanNTPrasadRHAbduSSelf nanoemulsifying drug delivery system (SNEDDS) of rosuvastatin calcium: design, formulation, bioavailability and pharmacokinetic evaluationColloids Surf B Biointerfaces201311233734324012665
  • GursoyRBenitaSSelf-emulsifying drug delivery systems (SEDDS) for improved oral delivery of lipophilic drugsBiomed Pharmacother20045817318215082340
  • ShegokarRMüllerRNanocrystals: industrially feasible multifunctional formulation technology for poorly soluble activesInt J Pharm201039912913920674732
  • JunghannsJMüllerRNanocrystal technology, drug delivery and clinical applicationsInt J Nanomedicine2008329530918990939
  • PatravaleVBDateAKulkarnRMNanosuspensions: a promising drug delivery strategyJ Pharm Pharmacol20105682784015233860
  • McKeeJRabinowBCookCGassJNanosuspension formulation of itraconazole eliminates the negative inotropic effect of SPORANOX in dogsJ Med Toxicol2010633133620238196
  • PatelGVPatelVBPathakARajputSJNanosuspension of efavirenz for improved oral bioavailability: formulation optimization, in vitro, in situ and in vivo evaluationDrug Dev Ind Pharm201440809123323843
  • PatelVRAgrawalYKNanosuspension: an approach to enhance solubility of drugsJ Adv Pharm Technol Res20112818722171298
  • DolencAKristlJBaumgartnerSPlaninsekOAdvantages of celecoxib nanosuspension formulation and transformation into tabletsInt J Pharm200937620421219426794
  • BasaliousEBShawkyNBadr-EldinSMSNEDDS containing bioenhancers for improvement of dissolution and oral absorption of lacidipine. I: development and optimizationInt J Pharm201039120321120214965
  • DateAANagarsenkerMSDesign and evaluation of self-nanoemulsifying drug delivery systems (SNEDDS) for cefpodoxime proxetilInt J Pharm200732916617217010543
  • ZhangPLiuYFengNXuJPreparation and evaluation of self-microemulsifying drug delivery system of oridoninInt J Pharm200835526927618242895
  • ElnaggarYEl-MassikMAbdallahOSelf-nanoemulsifying drug delivery systems of tamoxifen citrate: design and optimizationInt J Pharm200938013314119635537
  • ZhaoYWangCChowAHSelf-nanoemulsifying drug delivery system (SNEDDS) for oral delivery of Zedoary essential oil: formulation and bioavailability studiesInt J Pharm201038317017719732813
  • KhanAWKottaSAnsariSHSharmaRKAliJSelf-nanoemulsifying drug delivery system (SNEDDS) of the poorly water-soluble grapefruit flavonoid Naringenin: design, characterization, in vitro and in vivo evaluationDrug Deliv Epub 2014 Feb 10
  • TalegaonkarSMustafaGAkhterSIqbalZDesign and development of oral oil-in-water nanoemulsion formulation bearing atorvastatinJ Disper Sci Technol201031690701
  • LiuDXuHTianBFabrication of carvedilol nanosuspensions through the anti-solvent precipitation-ultrasonication method for the improvement of dissolution rate and oral bioavailabilityAAPS Pharm Sci Tech201213295304
  • KurakulaMSobahiTEl-HelwAAbdelaalMDevelopment and validation of a RP-HPLC method for assay of atorvastatin and its application in dissolution studies on thermosensitive hydrogel-based nanocrystalsTrop J Pharm Res20141316811687
  • Legislation for the protection of animals used for scientific purposes [webpage on the InternetBelgiumEuropean Commission2014 Available from: http://ec.europa.eu/environment/chemicals/lab_animals/legislation_en.htmAccessed December 15, 2014
  • Guiding Principles for the Care and Use of Vertebrate Animals in Research and Training [webpage on the Internet]BethesdaAmerican Phsiological Society2014 Available from: http://www.the-aps.org/mm/SciencePolicy/About/Policy-Statements/Guiding-Principles.htmlAccessed December 15, 2014
  • MustafaGKhanZBansalTTalegaonkarSPreparation and characterization of oil in water nano-reservoir systems for improved oral delivery of atorvastatinCurrent Nanoscience20095428440
  • DodiyaSSChavhanSSSawantKKKordeAGSolid lipid nanoparticles and nanosuspension formulation of saquinavir: preparation, characterization, pharmacokinetics and biodistribution studiesJ Microencapsul20112851552721728760
  • DodiyaSChavhanSKordeASawantKKSolid lipid nanoparticles and nanosuspension of adefovir dipivoxil for bioavailability improvement: formulation, characterization, pharmacokinetic and biodistribution studiesDrug Dev Ind Pharm20133973374322690834
  • ShanmugamSBaskaranRBalakrishnanPThapaPYongCSYooBKSolid self-nanoemulsifying drug delivery system (S-SNEDDS) containing phosphatidylcholine for enhanced bioavailability of highly lipophilic bioactive carotenoid luteinEur J Pharm Biopharm20117925025721550401
  • ParveenRBabootaSAliJAhujaAVasudevSAhmadSOil based nanocarrier for improved oral delivery of silymarin: in vitro and in vivo studiesInt J Pharm201141324525321549187
  • WangLJDongJFChenJEastoeJLLiXFDesign and optimization of a new self-nanoemulsifying drug delivery systemJ Colloid Interface Sci200933044344819038395
  • KanickyJRShahDOEffect of degree, type, and position of unsaturation on the pKa of long-chain fatty acidsJ Colloid Interface Sci200225620120712505514
  • LiuGZhangDJiaoYComparison of different methods for preparation of a stable riccardin D formulation via nanotechnologyInt J Pharm201242251652222119965
  • BaliVAliMAliJNanocarrier for the enhanced bioavailability of a cardiovascular agent: in vitro, pharmacodynamic, pharmacokinetic and stability assessmentInt J Pharm2011403465620969935
  • TamilvananSFormulation of multifunctional oil-in-water nanosized emulsions for active and passive targeting of drugs to otherwise inaccessible internal organs of the human bodyInt J Pharm2009381627619666097
  • XiaDQuanPPiaoHPreparation of stable nitrendipine nanosuspensions using the precipitation-ultrasonication method for enhancement of dissolution and oral bioavailabilityEur J Pharm Sci20104032533420417274
  • FilipposKSantipharpPYunhuiWNanosizing – Oral formulation development and biopharmaceutical evaluationAdv Drug Deliv Rev20075963164417601629
  • DressmanJReppasCIn vitro-in vivo correlations for lipophilic, poorly water-soluble drugsEur J Pharm Sci2000117380
  • MullerRHKeckCChallenges and solutions for the delivery of biotech drugs – a review of drug nanocrystal technology and lipid nanoparticlesJ Biotechnol200411315117015380654
  • ColomboIGrassiGGrassiMDrug mechanochemical activationJ Pharm Sci2009983961398619338060